atenolol has been researched along with chlorthalidone in 144 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 65 (45.14) | 18.7374 |
| 1990's | 38 (26.39) | 18.2507 |
| 2000's | 25 (17.36) | 29.6817 |
| 2010's | 14 (9.72) | 24.3611 |
| 2020's | 2 (1.39) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Barker, NP; Galloway, DB; Jeffers, TA; Petrie, JC; Webster, J | 1 |
| Gudbrandsson, T; Hansson, L | 1 |
| Boer, P; Geyskes, GG; Leenen, FH; Teeuw, AH | 1 |
| Bateman, DN; Bulpitt, CJ; Dean, CR; Dollery, CT; Mucklow, JC | 1 |
| Guevara, J; Hernandez-Pieretti, O; Morillo, J; Ramírez, A; Urbina-Quintana, A; Velasco, M | 2 |
| Boer, P; Dorhout Mees, EJ; Geyskes, GG; van Rooijen, GJ | 1 |
| Chatellier, G; Ménard, J | 1 |
| Amaro Cendón, A; Calvo Gómez, C; García Acuña, JM; Gil de la Peña, M; González-Juanatey, JR; Vega Fernández, M; Virgós Lamela, A | 1 |
| Blaufox, MD; Davis, B; Langford, H; Lee, HB; Oberman, A; Wassertheil-Smoller, S | 1 |
| Berge, KG; Petrovitch, H; Vogt, TM | 1 |
| Blaufox, MD; Cutler, JA; Davis, BR; Hawkins, CM; Langford, HG; Oberman, A; Wassertheil-Smoller, S; Zimbaldi, N | 1 |
| Applegate, WB | 1 |
| Durel, LA; Hayashi, PJ; Schneiderman, N; Weidler, DJ | 1 |
| Blaufox, MD; Davis, BR; Langford, HG; Oberman, AS; Wassertheil-Smoller, S; Wylie-Rosett, J | 1 |
| Blaufox, MD; Davis, B; Langford, H; Oberman, A; Wassertheil-Smoller, S | 1 |
| Kaplan, NM | 1 |
| Grigor'ev, IuV; Ivashkin, VT; Korneev, NV; Levitskiĭ, DN; Sinopal'nikov, AI; Virs, EA | 1 |
| Scapellato, L; Stornello, M; Valvo, EV | 1 |
| Aderounmu, AF; Falase, AO; Salako, LA; Walker, O | 1 |
| Gerstenblith, G | 1 |
| Palmelund, VO; Pilgaard, S; Svendsen, TL | 1 |
| Grigor'ev, IuV; Ivashkin, VT; Sinopal'nikov, AI | 1 |
| Brandini, V; Chieppa, S; De Simone, R; Giuliani, F; Iarussi, D; Langella, S; Lobascio, C | 1 |
| Applegate, WB; Borhani, NO; Curb, JD; Cutler, JA; Davis, BR; Furberg, CD; Hawkins, CM; Lakatos, E; Page, LB; Probstfield, JL | 1 |
| Alonso Rodríguez, C; Gayán Laviña, R; Gómez Marino, MA; Jiménez Ramos, A | 1 |
| Bailey, G; Barnett, AH; Chesner, IM; Odugbesan, O | 1 |
| Cumetti, C; De Cristofaro, A; Montanari, C; Roja, M; Vergani, A | 1 |
| Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O | 1 |
| Coburn, PC; Jacob, RG; Johnsen, AM; McDonald, RH; Reeves, RA; Shapiro, AP | 1 |
| Lamon, KD | 1 |
| Contursi, V; Di Lecce, G; Maiorano, G; Ricapito, M; Saracino, E | 1 |
| Azevedo, Ade C; Bosco, J; Célnik, D; do Patrocínio, LL; Kruczan, DD; Mohallen, KL; Pinheiro, L; Sekeff, JA; Weitzel, LH | 1 |
| Hölzle, E; Lehmann, P; Plewig, G | 1 |
| Curry, RC; Schwartz, KM; Urban, PL | 1 |
| Bowman, CA; Jeffcoate, WJ | 1 |
| Petrella, V | 1 |
| Jacob, RG; Lehoczky, JP; Marler, MR; Shapiro, AP | 1 |
| Capra, A; Leonetti, G; Pasotti, C | 1 |
| Amery, A; Fagard, R; Fiocchi, R; Lijnen, P; M'Buyamba-Kabangu, JR; Staessen, J | 1 |
| Coxhead, PF; Douglas-Jones, AP | 1 |
| Bisi, G; Fabbri, G; Franchi, F; Galanti, G; Lo Sapio, P; Matassi, L; Pedenovi, P; Righi, D | 1 |
| Giannola, A; Immordino, R; Novo, S; Strano, A | 1 |
| Garrett, BN; Maxwell, MH; Saunders, E; Schnaper, H | 1 |
| Ambrosioni, E; Borghi, C; Costa, FV; Mussi, A | 1 |
| Bovenzi, F; Contursi, V; Loiacono, N; Maiorano, G; Petrelli, G; Ricapito, M | 1 |
| Poulter, NR; Sanderson, JE | 1 |
| Adalio, G; Budriesi, N; Turina, MC; Zamboni, A | 1 |
| Avantaggiato, F; Balestrazzi, M; Chiarappa, R; De Cesaris, R; Grimaldi, A; Ranieri, G | 1 |
| Backhouse, CI; Edwards, KG; Hosie, J; Tweed, JA | 1 |
| Catalano, M; Libretti, A; Parini, J; Romano, M | 1 |
| Baroni, MC; Butturini, U; Crotti, G; Delsignore, R; Mineo, F | 1 |
| Conway, J | 1 |
| Campana, C; Ferrario, M; Montemartini, C; Tondi, C | 1 |
| Kale, PA; Soman, RN | 1 |
| Hengeveld, WL; Schouten, JA; Westerman, RF | 1 |
| Giannola, A; Gullotti, D; Immordino, R; Novo, S; Strano, A | 1 |
| Calabrò, ML; Ficarra, P; Ficarra, R; Guarniera Fenech, C; Tommasini, A | 1 |
| Cocco, F; Dessì Fulgheri, P; Dettori, S; Fiori, C; Glorioso, N; Madeddu, P; Rappelli, A; Sanna, G | 1 |
| Brandstetter, G; Hoffmann, H | 1 |
| Schoeman, HS; Sommers, DK; van Wyk, M | 1 |
| Born, A; Emanueli, A; Lavezzari, M | 1 |
| Alleyne, GA; Forrester, TE; Grell, GA | 1 |
| Bahadur, MM; Misra, NP | 1 |
| Grell, GA | 1 |
| Fogari, R; Zoppi, A | 1 |
| Coltorti, M; Gentile, S | 1 |
| Zhao, GS | 1 |
| Dobbs, RJ; Phillips, RJ; Robinson, BF | 1 |
| Hausen, T | 1 |
| Seedat, YK | 1 |
| Nissinen, A; Tuomilehto, J | 1 |
| Asbury, MJ; Barker, NP; Wells, FO | 1 |
| Chadha, DR; Houtzagers, JJ | 1 |
| Otter, HP | 1 |
| Gotzen, R; Hiemstra, S | 1 |
| Centritto, V | 1 |
| Alleyne, GA; Anderson, M; Grell, GA; Robinson, HM | 1 |
| Albanesi Filho, FM; Brandão, AP; Oigman, W | 1 |
| Bastain, W; Farina, PL; McAinsh, J; Riva, E; Sega, R; Tognoni, G | 1 |
| Mhlongo, SW | 1 |
| Amaro Cendón, A; Calvo Gómez, C; Castelo Fuentes, V; de la Peña, MG; García Acuña, JM; González-Juanatey, JR; Pose Reino, A | 1 |
| Blaufox, MD; Davis, BR; Kirchner, K; Langford, HG; Oberman, A; Wassertheil-Smoller, S; Wylie-Rosett, J; Zimbaldi, N | 1 |
| Ambrosio, GB; Casiglia, E; Colangeli, G; Di Menza, G; Ginocchio, G; Mazza, A; Onesto, C; Pegoraro, L; Spolaore, P | 1 |
| Applegate, WB; Camel, GH; Greenlick, MR; Hadley, E; Luhr, J; Moye, L; Perry, HM; Pressel, S; Shekelle, RB; Wittes, J | 1 |
| Alli, C; Avanzini, F; Bettelli, G; Colombo, F; Corso, R; Mariotti, G; Radice, M; Tognoni, G; Torri, V | 1 |
| Andriani, A; Bonfantino, MV; De Cesaris, R; Filitti, V; Lamontanara, G; Ranieri, G; Salvetti, A; Taddei, S | 1 |
| Maharaj, B; van der Byl, K | 1 |
| Bosch, M; Delgadillo, J; Leiva, F | 1 |
| Blaufox, MD; Cutler, JA; Davis, BR; Kirchner, K; Langford, HG; Oberman, A; Wassertheil-Smoller, S; Zimbaldi, N | 1 |
| Blaufox, MD; Davis, BR; Hataway, H; Jennings, S; Langford, HG; Oberman, A; Stern, J; Wassertheil-Smoller, S; Wylie-Rosett, J; Zimbaldi, N | 1 |
| Applegate, WB; Black, H; Camel, G; Curb, JD; Cutler, JA; Davis, BR; Frost, PH; Gonzalez, N; Guthrie, G; Oberman, A; Pressel, SL; Rutan, GH; Savage, PJ; Stamler, J | 1 |
| Berge, KG; Davis, BR; Hawkins, CM; Kostis, JB; Probstfield, J | 1 |
| de Leeuw, PW; Notter, T; Zilles, P | 1 |
| Applegate, WB; Berge, KG; Berkson, DM; Black, HR; Blaufox, MD; Cohen, JD; Curb, JD; Cutler, J; Davis, BR; Grimm, RH; Kostis, JB; Lacy, CR; McDonald, R; Perry, HM; Schron, E; Smith, WM; Wassertheil-Smoller, S | 1 |
| Canali, S; Giachetti, C; Tenconi, A; Zanolo, G | 1 |
| Castello, R; Cohen, JD; Labovitz, AJ; Martin, TJ; Ofili, EO; Pearson, A; St Vrain, JA; Uy, ND | 1 |
| Brass, LM; Burlando, A; Cohen, J; Davis, BR; Frishman, W; Frost, PH; Price, T; Stamler, J; Vogt, T; Wilson, A | 1 |
| Singer, RB | 1 |
| Anderson, GM; Clark, JP; Gurwitz, JH; Lau, P; Rochon, PA; Shear, NH; Tu, JV | 1 |
| Gómez Guindal, JA; González Lama, I; González Maqueda, I | 1 |
| Applegate, WB; Davis, BR; Fields, WS; Guralnik, JM; Kuller, L; Perry, HM; Pressel, S; Price, TR; Probstfield, JL; Stamler, J | 1 |
| Wehner, W | 1 |
| Applegate, WB; Di Bari, M; Franse, LV; Pahor, M; Shorr, RI; Somes, GW; Wan, JY | 1 |
| Crivelli, F; Dal Bo, L; Ismaili, S; Marzo, A; Mazzucchelli, P; Monti, NC; Porziotta, E; Ronchi, C; Tettamanti, RA; Uhr, MR | 1 |
| Huysmans, FT; Wetzels, JF | 1 |
| Applegate, WB; Di Bari, M; Ferrucci, L; Franse, LV; Pahor, M; Shorr, RI; Somes, GW; Wan, JY | 1 |
| Applegate, WB; Chen, JG; DiBari, M; Ferrucci, L; Furberg, CD; Guralnik, JM; Pahor, M; Penninx, BW; Williamson, JD | 1 |
| Serkova, VK; Sheverda, NV | 1 |
| Beck, K; Holzgreve, H; Janka, HU; Nakov, R | 1 |
| Castellano, PM; Ferraro, MC; Kaufman, TS | 1 |
| Diener, HC | 1 |
| El-Gindy, A; Emara, S; Mostafa, A | 1 |
| Mohamed, Ael-M; Salem, H | 1 |
| Fomin, VV; Moiseev, SV | 1 |
| Colon, P; Crow, R; Cutler, JA; Davis, BR; Dunn, K; Ellsworth, A; Franklin, S; Furberg, C; Goff, D; Golden, J; Leenen, F; Mohiuddin, S; Papademetriou, V; Piller, LB; Proschan, M | 1 |
| Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT | 1 |
| Abdel-Salam, RA; El-Gindy, A; Sallam, S | 1 |
| Kostis, JB; Vagaonescu, TD; Wilson, AC | 1 |
| Chandurkar, N; Joglekar, VK; Karnik, N; Naik, GS; Pareek, A; Salagre, SB; Zawar, SD | 1 |
| Appel, LJ; Klag, MJ; Miller, ER; Parekh, RS; Shafi, T | 1 |
| Aboul-Enein, HY; Al Azzam, KM; Saad, B | 1 |
| Cabrera, J; Cosgrove, NM; Davis, BR; Kostis, JB; Kostis, WJ; Pantazopoulos, JS; Pressel, SL; Sedjro, JE | 1 |
| Cabrera, J; Cheng, JQ; Cosgrove, NM; Davis, BR; Deng, Y; Kostis, JB; Kostis, WJ; Messerli, FH; Sedjro, JE; Swerdel, JN | 1 |
| Jeffers, BW; Wang, JG; Yan, P | 1 |
| Beutler, D; Bosak, A; Graeme, K; Heise, CW; Loli, A; Orme, G | 1 |
| Abd El-Hady, D; Albishri, HM; Tayeb, RA | 1 |
| Patel, DP; Sanyal, M; Shah, JV; Shah, PA; Shrivastav, PS | 1 |
| Holzgreve, H | 1 |
| Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Simpson, LM | 1 |
| Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Shmerling, RH; Simpson, LM | 1 |
| Aboul-Enein, HY; El-Azzouny, AA; Fouad, MA; Hassan, RM; Saleh, OA | 1 |
9 review(s) available for atenolol and chlorthalidone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments].
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Cerebrovascular Disorders; Chlorthalidone; Coronary Disease; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged | 1992 |
Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
Topics: Aged; Atenolol; Cerebrovascular Disorders; Chlorthalidone; Coronary Disease; Double-Blind Method; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Reserpine | 1992 |
Systolic hypertension in older persons.
Topics: Aged; Aging; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Double-Blind Method; Humans; Hypertension; Prevalence; Reserpine | 1992 |
Safety profile of celiprolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Celiprolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Propanolamines; Propranolol | 1988 |
[Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Drug Tolerance; Humans; Hypertension; Indoles; Patient Compliance; Time Factors; Vasodilator Agents; Verapamil | 1999 |
[Intensive treatment of blood pressure in patients with kidney disease and proteinuria].
Topics: Antihypertensive Agents; Atenolol; Chlorthalidone; Dose-Response Relationship, Drug; Enalapril; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Male; Middle Aged; Obesity; Proteinuria; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2000 |
[Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Carotid Artery Diseases; Carotid Artery, Common; Chlorthalidone; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Ultrasonography; Vasodilator Agents; Verapamil | 2005 |
Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Enalapril; Humans; Hypertension; Lisinopril; Losartan; Randomized Controlled Trials as Topic | 2014 |
80 trial(s) available for atenolol and chlorthalidone
| Article | Year |
|---|---|
Atenolol, methyldopa, and chlorthalidone in moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Propanolamines | 1977 |
Combination therapy with saluretics and atenolol in essential hypertension. Effects on blood pressure, electrolytes and uric acid.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bendroflumethiazide; Chlorthalidone; Diuretics; Drug Evaluation; Drug Therapy, Combination; Electrolytes; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Mefruside; Middle Aged; Propanolamines; Uric Acid | 1979 |
Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
Topics: Adult; Ambulatory Care; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propanolamines; Renin; Time Factors | 1979 |
Atenolol and chlorthalidone in combination for hypertension.
Topics: Adolescent; Adult; Atenolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Middle Aged; Propanolamines; Pulse; Time Factors | 1979 |
Mechanism of the haemodynamic interaction between atenolol, a cardioselective beta-adrenoreceptor-blocking agent, and chlorthalidone in hypertensive patients.
Topics: Adult; Aged; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Middle Aged; Placebos; Propanolamines; Regional Blood Flow; Vascular Resistance | 1979 |
Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
Topics: Administration, Oral; Adult; Atenolol; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Double-Blind Method; Evaluation Studies as Topic; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propanolamines; Propranolol; Renin | 1979 |
[Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols].
Topics: Adult; Aged; Atenolol; Blood Pressure; Cardiomegaly; Chlorthalidone; Electrocardiography; Enalapril; Exercise Test; Heart Rate; Humans; Hypertension; Male; Middle Aged; Time Factors | 1992 |
Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy.
Topics: Adult; Aged; Atenolol; Chlorthalidone; Diastole; Humans; Hypertension; Middle Aged; Regression Analysis; Renin; Sodium, Dietary; Weight Loss | 1992 |
Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
Topics: Aged; Atenolol; Cerebrovascular Disorders; Chlorthalidone; Coronary Disease; Double-Blind Method; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Reserpine | 1992 |
Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group.
Topics: Atenolol; Chlorthalidone; Combined Modality Therapy; Energy Intake; Exercise; Female; Humans; Hypertension; Male; Potassium; Smoking; Sodium, Dietary; Weight Loss | 1992 |
Systolic hypertension in older persons.
Topics: Aged; Aging; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Double-Blind Method; Humans; Hypertension; Prevalence; Reserpine | 1992 |
Effectiveness of antihypertensive medications in office and ambulatory settings: a placebo-controlled comparison of atenolol, metoprolol, chlorthalidone, verapamil, and an atenolol-chlorthalidone combination.
Topics: Adult; Ambulatory Care; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Determination; Chlorthalidone; Double-Blind Method; Drug Combinations; Humans; Hypertension; Metoprolol; Middle Aged; Monitoring, Physiologic; Office Visits; Verapamil | 1992 |
The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension.
Topics: Atenolol; Black People; Body Mass Index; Chlorthalidone; Combined Modality Therapy; Female; Humans; Hypertension; Male; Middle Aged; Regression Analysis; Weight Loss; White People | 1992 |
The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Body Weight; Cardiovascular Diseases; Chlorthalidone; Female; Humans; Hypertension; Male; Middle Aged; Quality of Life; Risk Factors; Weight Loss | 1992 |
Commentary on the Trial of Antihypertensive Interventions and Management (TAIM) Study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Female; Humans; Hypertension; Male; Middle Aged; Weight Loss | 1992 |
Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria.
Topics: Atenolol; Blood Pressure; Chlorthalidone; Chronic Disease; Diabetic Nephropathies; Diabetic Retinopathy; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Proteinuria | 1991 |
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Cause of Death; Cerebrovascular Disorders; Chlorthalidone; Contraindications; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Male; Middle Aged; Morbidity; Placebos | 1991 |
Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Double-Blind Method; Drug Combinations; Female; Heart Rate; Humans; Male; Middle Aged; Nigeria; Randomized Controlled Trials as Topic | 1990 |
Special considerations in the elderly patient.
Topics: Age Factors; Aged; Aging; Atenolol; Blood Pressure; Cardiac Output; Cardiomegaly; Chlorthalidone; Dose-Response Relationship, Drug; Echocardiography; Humans; Hypertension; Middle Aged; Myocardial Contraction; Risk Factors; Verapamil | 1990 |
[A comparative study of atenolol (Tenormin) and the combined preparation atenolol/chlorthalidone (Tenoretic Mite) in essential hypertension. A randomized double-blind study from general practice].
Topics: Adolescent; Adult; Aged; Atenolol; Chlorthalidone; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
[Effectiveness of long-term antihypertensive therapy with tenoretic--a combined long-acting drug].
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Drug Combinations; Humans; Hypertension; Middle Aged; Time Factors | 1990 |
The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.
Topics: Aged; Antihypertensive Agents; Atenolol; Cerebrovascular Disorders; Chlorthalidone; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Systole | 1989 |
Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Atenolol; Chlorthalidone; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Male; Maximal Midexpiratory Flow Rate; Metoprolol; Oxprenolol; Random Allocation | 1986 |
Relaxation therapy for hypertension. Comparison of effects with concomitant placebo, diuretic, and beta-blocker.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Chlorthalidone; Combined Modality Therapy; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Placebos; Pulse; Relaxation Therapy; Renin; Sodium | 1986 |
Safety profile of celiprolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Celiprolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Propanolamines; Propranolol | 1988 |
[Normalization of ventricular compliance and hypertrophy in arterial hypertension. Double-blind study with 2 combinations of a beta blocker and diuretic].
Topics: Adult; Atenolol; Blood Pressure; Cardiomegaly; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Elasticity; Female; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction | 1987 |
Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.
Topics: Adult; Analysis of Variance; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Quality of Life; Random Allocation; Supination | 1988 |
Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Potassium | 1986 |
Chronic treatment with tibalosine in essential hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Potassium; Propanolamines; Random Allocation | 1986 |
A general practice trial of antihypertensive therapy comparing a combination of nicardipine and chlorthalidone with atenolol and chlorthalidone.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Middle Aged; Nicardipine; Nifedipine | 1986 |
[Systolic-diastolic function of the left ventricle and flowmetry of the lower limbs in the treatment of moderate essential arterial hypertension with atenolol-chlorthalidone].
Topics: Adult; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Leg; Male; Middle Aged; Plethysmography; Random Allocation | 1986 |
[Results of a multicenter trial of antihypertensive treatment with atenolol, alone or in combination with chlorthalidone, of patients with mild, moderate and severe hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged | 1987 |
Cadralazine and chlorthalidone as a second-step drug with atenolol in hypertensive patients: differences in blood pressure control during exercise.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Chemical Analysis; Blood Pressure; Body Weight; Chlorthalidone; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Pyridazines | 1986 |
Atenolol and chlorthalidone in combination in the management of older hypertensive patients: a randomized clinical trial.
Topics: Aged; Atenolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1985 |
Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pyridazines | 1985 |
[Therapeutic prospectives in the field of hypertension].
Topics: Adult; Aged; Atenolol; Chlorthalidone; Clinical Trials as Topic; Drug Combinations; Drug Tolerance; Humans; Hypertension; Middle Aged | 1985 |
Third-line therapy. A cautionary note.
Topics: Atenolol; Bendroflumethiazide; Captopril; Chlorthalidone; Female; Humans; Hypertension; Male; Methyldopa; Nifedipine | 1985 |
[Atenolol-chlorthalidone combination vs placebo: controlled clinical trial in patients with medium-mild arterial hypertension].
Topics: Adult; Aged; Atenolol; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Hypertension; Male; Middle Aged | 1985 |
Atenolol as an anti-hypertensive drug.
Topics: Antihypertensive Agents; Atenolol; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension | 1985 |
Prazosin once or twice daily?
Topics: Adult; Aged; Amiloride; Atenolol; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Posture; Prazosin; Propranolol; Quinazolines | 1985 |
[Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
Topics: Adult; Aged; Atenolol; Celiprolol; Chlorthalidone; Drug Combinations; Drug Tolerance; Female; Humans; Hypertension; Male; Middle Aged; Propanolamines; Uric Acid | 1984 |
The effects of two combinations of a beta-blocker and a diuretic on diuresis in normal subjects.
Topics: Adult; Atenolol; Chlorthalidone; Clinical Trials as Topic; Diuresis; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Male; Potassium; Sodium; Sotalol; Uric Acid; Urine | 1984 |
A study on the treatment of arterial hypertension with atenolol/chlorthalidone tablets: preliminary results of a post-marketing surveillance clinical trial on 2449 patients.
Topics: Adult; Aged; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Time Factors | 1984 |
Comparison of the effectiveness of a beta blocker (atenolol) and a diuretic (chlorthalidone) in black hypertensive patients.
Topics: Adult; Atenolol; Black People; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Jamaica; Male; Middle Aged; Pulse; Time Factors | 1984 |
Atenolol in hypertension.
Topics: Atenolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1984 |
Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.
Topics: Administration, Oral; Adult; Aged; Atenolol; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Middle Aged; Placebos; Propanolamines | 1980 |
Trial of atenolol and chlorthalidone for hypertension in black South Africans.
Topics: Atenolol; Black People; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Propanolamines; Random Allocation; South Africa | 1980 |
Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone.
Topics: Adult; Antihypertensive Agents; Atenolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Propanolamines | 1980 |
Once daily combination therapy for hypertension.
Topics: Adolescent; Adult; Aged; Atenolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged | 1980 |
Once-daily penbutolol or atenolol can replace combination therapy in essential hypertension.
Topics: Atenolol; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Metoprolol; Penbutolol; Propanolamines; Propranolol; Pulse | 1982 |
[The midterm inefficacy of 2 different dosages of chlorthalidone (50 and 25 mg/day) in the regression of left ventricular mass in arterial hypertension].
Topics: Aged; Atenolol; Blood Pressure; Chi-Square Distribution; Chlorthalidone; Enalapril; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prospective Studies; Remission Induction; Time Factors | 1995 |
Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management.
Topics: Adult; Antihypertensive Agents; Atenolol; Chlorthalidone; Combined Modality Therapy; Diet, Sodium-Restricted; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Potassium; Potassium, Dietary; Proportional Hazards Models; Sodium; Treatment Outcome | 1994 |
Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL).
Topics: Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Clonidine; Drug Therapy, Combination; Female; Heart Diseases; Humans; Hypertension; Italy; Male; Nifedipine; Prospective Studies; Survival Analysis | 1994 |
Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Atenolol; Cerebrovascular Disorders; Chlorthalidone; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Leisure Activities; Male; Middle Aged; Quality of Life; Reserpine; Self Care; Systole | 1994 |
Antihypertensive efficacy and tolerability of different drug regimens in isolated systolic hypertension in the elderly.
Topics: Aged; Aged, 80 and over; Amiloride; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Nifedipine; Patient Satisfaction; Treatment Outcome | 1994 |
The effects of diuretic and beta-blocker treatment on cardiac and vascular structural changes in untreated essential hypertensive patients.
Topics: Adult; Atenolol; Blood Pressure; Chlorthalidone; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Ultrasonography; Vascular Resistance | 1993 |
Randomised double-blind comparative study of efficacy and safety of hydroflumethiazide and reserpine and chlortalidone and atenolol in the treatment of mild to moderate hypertension in black patients.
Topics: Adult; Antihypertensive Agents; Atenolol; Black People; Chlorthalidone; Double-Blind Method; Drug Combinations; Humans; Hydroflumethiazide; Hypertension; Male; Reserpine | 1993 |
Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Proportional Hazards Models; Treatment Outcome; Weight Loss | 1993 |
Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention.
Topics: Adult; Analysis of Variance; Atenolol; Blood Pressure; Body Weight; Chlorthalidone; Combined Modality Therapy; Diet Records; Diet, Reducing; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Potassium; Potassium, Dietary; Sodium; Sodium, Dietary | 1993 |
Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Blood Pressure; Cerebrovascular Disorders; Chlorthalidone; Coronary Disease; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Reserpine; Systole | 1993 |
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Chlorthalidone; Dementia; Depression; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Proportional Hazards Models; Risk | 1996 |
Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
Topics: Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Chlorthalidone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Reserpine; Risk; Risk Factors; Systole | 1995 |
Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Safety; Verapamil | 1997 |
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
Topics: Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Diuretics; Double-Blind Method; Electrocardiography; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Survival Analysis; Systole | 1997 |
Effect of treatment of isolated systolic hypertension on left ventricular mass.
Topics: Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Diuretics; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Randomized Controlled Trials as Topic; Systole; Ultrasonography | 1998 |
Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Chlorthalidone; Double-Blind Method; Female; Humans; Hypertension; Incidence; Male; Proportional Hazards Models; Reserpine; Risk Factors; Systole | 1998 |
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).
Topics: Aged; Antihypertensive Agents; Atenolol; Brain Ischemia; Cerebral Hemorrhage; Chlorthalidone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Reserpine; Stroke; Systole | 2000 |
Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Biomarkers; Cardiovascular Diseases; Chlorthalidone; Cohort Studies; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Reserpine; Stroke; Uric Acid | 2000 |
Comparative bioavailability of two formulations containing atenolol and chlortalidone associated in a 4:1 fixed combination.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Area Under Curve; Atenolol; Benzothiadiazines; Biological Availability; Chlorthalidone; Diuretics; Drug Combinations; Female; Half-Life; Humans; Male; Sodium Chloride Symporter Inhibitors; Therapeutic Equivalency | 2000 |
Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.
Topics: Aged; Antihypertensive Agents; Atenolol; Bias; Chlorthalidone; Dementia; Disabled Persons; Double-Blind Method; Female; Humans; Hypertension; Incidence; Multicenter Studies as Topic; Patient Dropouts; Randomized Controlled Trials as Topic; Reserpine; Surveys and Questionnaires; Treatment Outcome | 2001 |
Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.
Topics: Age Factors; Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Reserpine; Risk Assessment; Risk Factors; Sex Distribution; Systole; Treatment Outcome | 2001 |
Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Biomarkers; Blood Glucose; Blood Pressure; Chlorthalidone; Diabetes Mellitus, Type 2; Diastole; Diuretics; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Patient Compliance; Systole; Treatment Outcome; Vasodilator Agents; Verapamil | 2003 |
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Treatment Outcome | 2006 |
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People | 2007 |
Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study.
Topics: Aged; Aged, 80 and over; Aging; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Blood Pressure; Cause of Death; Chlorthalidone; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Male; Middle Aged; Risk Factors | 2008 |
Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
Topics: Adult; Antihypertensive Agents; Atenolol; Chlorthalidone; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2008 |
Changes in serum potassium mediate thiazide-induced diabetes.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Hypokalemia; Incidence; Male; Middle Aged; Potassium; Proportional Hazards Models; Reserpine; Risk Factors | 2008 |
Visit-to-visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly Program.
Topics: Age Factors; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Longitudinal Studies; Male; Office Visits; Patient Compliance; Survival Rate; Treatment Outcome | 2014 |
Competing cardiovascular and noncardiovascular risks and longevity in the systolic hypertension in the elderly program.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Chlorthalidone; Female; Humans; Hypertension; Longevity; Male; Middle Aged; Risk Factors; Survival Analysis; Treatment Outcome | 2014 |
[No antihypertensive drugs for frail elderly?].
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Cause of Death; Chlorthalidone; Drug Therapy, Combination; Female; Frail Elderly; Humans; Hypertension; Male; Middle Aged; Physical Fitness; Treatment Outcome | 2016 |
58 other study(ies) available for atenolol and chlorthalidone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Prolonged cardioselective blockade of beta-1 adrenoreceptors in combination with increased diuresis as a method of choice in the treatment of hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Drug Combinations; Humans; Hypertension; Middle Aged | 1991 |
[Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle
Topics: Adult; Aged; Atenolol; Cardiomyopathy, Hypertrophic; Chlorthalidone; Diastole; Drug Evaluation; Drug Therapy, Combination; Female; Gallopamil; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Systole | 1989 |
[Value of heart rate recordings in selecting the initial treatment of hypertension].
Topics: Adult; Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1989 |
Hazards of combined beta-blocker/diuretic tablets.
Topics: Antihypertensive Agents; Atenolol; Chlorthalidone; Drug Combinations; Female; Humans; Hypokalemia; Middle Aged; Ventricular Fibrillation | 1985 |
Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Chlorthalidone; Diuretics; Drug Therapy, Combination; Exercise Test; Heart Rate; Humans; Hypertension; Labetalol; Male | 1985 |
[Cardiovascular response to isometric exercise test during beta blocker and diuretic treatment in essential arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Chlorthalidone; Diuretics; Drug Evaluation; Drug Therapy, Combination; Exercise Test; Female; Heart Rate; Humans; Hypertension; Isometric Contraction; Male; Metoprolol; Middle Aged; Time Factors | 1988 |
[Photoallergy to Neotri and cross reaction to tenoretic--detection by systemic photoprovocation].
Topics: Aged; Atenolol; Chlorthalidone; Diuretics; Drug Combinations; Drug Eruptions; Humans; Hypertension; Male; Patch Tests; Photosensitivity Disorders; Skin Tests; Triamterene; Ultraviolet Rays; Xipamide | 1988 |
Severe salt and water deficiency associated with a combination of atenolol and chlorthalidone.
Topics: Aged; Atenolol; Chlorthalidone; Drug Combinations; Female; Humans; Water-Electrolyte Imbalance | 1988 |
[Thrombocytopenia caused by drugs: new molecules as the cause].
Topics: Aged; Aged, 80 and over; Atenolol; Captopril; Chlorthalidone; Drug Therapy, Combination; Female; Humans; Hypertension; Middle Aged; Thrombocytopenia | 1987 |
The statistical analysis of treatment effects in 24-hour ambulatory blood pressure recordings.
Topics: Activity Cycles; Ambulatory Care; Atenolol; Blood Pressure; Blood Pressure Determination; Chlorthalidone; Circadian Rhythm; Humans; Hypertension; Monitoring, Physiologic; Regression Analysis; Relaxation; Statistics as Topic | 1988 |
Postmarketing survey of the effects of an atenolol/chlorthalidone combination in the treatment of hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing | 1987 |
[Clinico-therapeutic evaluation of the hypertensive patient by the isometric exertion test].
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Clonidine; Female; Humans; Hypertension; Isometric Contraction; Male; Metoprolol; Middle Aged; Muscle Contraction | 1986 |
Reserpine versus beta-blocker as an additive to a diuretic in the treatment of Kenyan hypertensives.
Topics: Antihypertensive Agents; Atenolol; Chlorthalidone; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Quinazolines; Reserpine; Sulfonamides | 1986 |
[Long-term therapy with atenolol and chlorthalidone in medium- and high-grade arterial hypertension].
Topics: Adult; Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged | 1986 |
Changes in blood pressure and thermographic values resulting from use of a beta-blocker plus diuretic and of an alpha-beta-blocker plus diuretic.
Topics: Adult; Atenolol; Body Temperature; Chlorthalidone; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Labetalol; Middle Aged; Thermography | 1985 |
[Effects of atenolol and an atenolol-chlorthalidone combination on blood pressure values in hypertensive patients].
Topics: Adult; Aged; Atenolol; Blood Pressure; Chlorthalidone; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Posture | 1985 |
[HPLC determination of atenolol and chlorthalidone associated in pharmaceutical preparations].
Topics: Atenolol; Chlorthalidone; Chromatography, High Pressure Liquid; Drug Combinations | 1985 |
[Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Atenolol; Chlorthalidone; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Metoprolol; Middle Aged; Prazosin; Renin; Sotalol; Spironolactone | 1981 |
Low dose thiazide combined with a beta blocker.
Topics: Atenolol; Chlorthalidone; Drug Therapy, Combination; Humans; Hypertension; Propanolamines | 1983 |
Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
Topics: Age Factors; Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Drug Combinations; Drug Tolerance; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1984 |
Hypotensive effect of the association atenolol-chlorthalidone in hypertensive diabetics.
Topics: Adult; Aged; Atenolol; Blood Glucose; Blood Pressure; Chlorthalidone; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1984 |
[A short-term clinical observation during the treatment of essential hypertension by atenolol composite tablets].
Topics: Adult; Atenolol; Chlorthalidone; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Tablets | 1984 |
Effect of treatment with chlorthalidone and atenolol on response to dilator agents in the forearm resistance vessels of men with primary hypertension.
Topics: Adult; Aged; Atenolol; Chlorthalidone; Forearm; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Regional Blood Flow; Vascular Resistance; Vasodilator Agents; Verapamil | 1983 |
[Withdrawal syndrome following beta blocker therapy (author's transl)].
Topics: Adult; Angina Pectoris; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Middle Aged; Myocardial Infarction; Oxprenolol; Patient Dropouts; Propanolamines; Substance Withdrawal Syndrome | 1981 |
[Hypertensive therapy. Improvement of compliance with a daily regimen of a two-drug combination].
Topics: Atenolol; Blood Pressure; Chlorthalidone; Double-Blind Method; Drug Combinations; Heart Rate; Humans; Hypertension; Patient Compliance; Propanolamines; Random Allocation | 1982 |
Total body and serum potassium during treatment with atenolol in combination with chlorthalidone.
Topics: Adult; Antihypertensive Agents; Atenolol; Body Composition; Chlorthalidone; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Potassium; Propanolamines | 1981 |
[Use of metoprolol and atenolol, singly or in combination with a diuretic, in the treatment of arterial hypertension].
Topics: Adult; Atenolol; Chlorthalidone; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propanolamines | 1980 |
Treatment of Jamaican hypertensives with atenolol and chlorthalidone.
Topics: Adolescent; Adult; Antihypertensive Agents; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Jamaica; Male; Middle Aged; Propanolamines | 1981 |
[Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].
Topics: Adult; Aged; Amiloride; Atenolol; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propanolamines; Pyrazines; Timolol | 1981 |
Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone.
Topics: Adult; Atenolol; Chlorthalidone; Drug Therapy, Combination; Half-Life; Humans; Hypertension; Male; Propanolamines | 1980 |
Atenolol and chlorthalidone for hypertension in black South Africans.
Topics: Atenolol; Black or African American; Black People; Chlorthalidone; Diet; Humans; Hypertension; Propanolamines; Sodium Chloride; South Africa | 1980 |
[Thrombocytopenia from a pharmacological cause].
Topics: Atenolol; Chlorthalidone; Drug Therapy, Combination; Humans; Hypertension; Male; Middle Aged; Thrombocytopenia | 1993 |
Simultaneous determination of atenolol and chlorthalidone in plasma by high-performance liquid chromatography. Application to pharmacokinetic studies in man.
Topics: Antihypertensive Agents; Atenolol; Chlorthalidone; Chromatography, High Pressure Liquid; Humans; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 1997 |
Stroke in the elderly treated for systolic hypertension (SHEP).
Topics: Actuarial Analysis; Age Factors; Aged; Aged, 80 and over; Atenolol; Cerebrovascular Disorders; Chlorthalidone; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reserpine; Risk Factors | 1991 |
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Confidence Intervals; Databases as Topic; Diuretics; Drug Compounding; Evaluation Studies as Topic; Female; Humans; Hydrochlorothiazide; Logistic Models; Male; Metolazone; Metoprolol; Myocardial Infarction; Odds Ratio; Ontario; Propranolol; Retrospective Studies; Sex Factors; Sodium Chloride Symporter Inhibitors; Timolol | 1999 |
Determination of atenolol/chlortalidone during dissolution of tablets with UV multicomponent analysis.
Topics: Atenolol; Chlorthalidone; Drug Combinations; Regression Analysis; Spectrophotometry, Ultraviolet; Tablets | 2000 |
[Effect of atenolol combined with chlortalidone on characteristics of 24-hour blood pressure monitoring].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Chlorthalidone; Circadian Rhythm; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Time Factors | 2002 |
Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms.
Topics: Algorithms; Antihypertensive Agents; Atenolol; Calibration; Chlorthalidone; Drug Combinations; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets | 2003 |
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Aspirin; Atenolol; Atrial Fibrillation; Carotid Artery, Internal; Carotid Stenosis; Chlorthalidone; Clinical Trials as Topic; Diabetes Complications; Diuretics; Doxazosin; Female; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Life Style; Losartan; Male; Neurology; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk Factors; Simvastatin; Smoking; Societies, Medical; Stroke | 2003 |
HPLC and chemometric-assisted spectrophotometric methods for simultaneous determination of atenolol, amiloride hydrochloride and chlorthalidone.
Topics: Acetonitriles; Amiloride; Antihypertensive Agents; Atenolol; Chemistry, Pharmaceutical; Chlorthalidone; Chromatography, High Pressure Liquid; Heptanes; Least-Squares Analysis; Regression Analysis; Salts; Solutions; Spectrophotometry, Ultraviolet; Sulfonic Acids | 2005 |
Determination of antihypertensive mixtures by use of a chemometrics-assisted spectrophotometric method.
Topics: Amiloride; Antihypertensive Agents; Atenolol; Chlorthalidone; Least-Squares Analysis; Molecular Structure; Multivariate Analysis; Regression Analysis; Sensitivity and Specificity; Spectrophotometry | 2005 |
HPLC method for the simultaneous determination of atenolol and chlorthalidone in human breast milk.
Topics: Adult; Antihypertensive Agents; Atenolol; Chlorthalidone; Chromatography, High Pressure Liquid; Female; Humans; Milk, Human | 2008 |
Simultaneous determination of atenolol, chlorthalidone and amiloride in pharmaceutical preparations by capillary zone electrophoresis with ultraviolet detection.
Topics: Amiloride; Atenolol; Chlorthalidone; Electrophoresis, Capillary; Molecular Structure; Pharmaceutical Preparations; Reproducibility of Results; Spectrophotometry, Ultraviolet | 2010 |
Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Atenolol; Cardiovascular Agents; Chlorthalidone; Combined Modality Therapy; Decontamination; Drug Overdose; Emergency Service, Hospital; Endoscopy, Digestive System; Extracorporeal Membrane Oxygenation; Female; Humans; Lisinopril; Multiple Organ Failure; Renal Dialysis; Shock, Cardiogenic; Tablets; Transcutaneous Electric Nerve Stimulation; Treatment Outcome | 2015 |
Cyclodextrin Micellar LC for Direct Selective Analysis of Combined Dosage Drugs in Urine.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Antihypertensive Agents; Atenolol; beta-Cyclodextrins; Bisoprolol; Chlorthalidone; Chromatography, Liquid; Drug Combinations; Humans; Hydrochlorothiazide; Limit of Detection; Male; Micelles; Sodium Dodecyl Sulfate | 2015 |
Simultaneous quantification of atenolol and chlorthalidone in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Atenolol; Chlorthalidone; Chromatography, High Pressure Liquid; Drug Stability; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2016 |
Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT Trial.
Topics: Accidental Falls; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Hypotension, Orthostatic; Incidence; Male; Medicare; Syncope; Treatment Outcome; United States | 2019 |
The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Female; Gout; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 2020 |
Experimental design optimization of simultaneous enantiomeric separation of atenolol and chlorthalidone binary mixture by high-performance liquid chromatography using polysaccharide-based stationary phases.
Topics: Atenolol; Chlorthalidone; Chromatography, High Pressure Liquid; Stereoisomerism | 2021 |